Clinical Trial Update: Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight Neonates for Prevention of Staphylococcal Sepsis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting safety and efficacy results for pagibaximab injected in very low birth weight neonates to prevent Staphylococcal sepsis; the Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcal Sepsis

Drugs mentioned

• Pagibaximab (pagibaximab)

Snippet

Sponsor: Biosynexus Incorporated | Conditions: Staphylococcal Sepsis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2011-10-24